Related Experiment Video
Updated: Apr 30, 2026

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms
Published on: April 17, 2026
Invasive micropapillary carcinoma: a distinct type of adenocarcinomas in the gastrointestinal tract
Katarzyna Guzińska-Ustymowicz1, Katarzyna Niewiarowska1, Anna Pryczynicz1
1Katarzyna Guzińska-Ustymowicz, Katarzyna Niewiarowska, Anna Pryczynicz, Department of General Pathomorphology, Medical University of Bialystok, 15-269 Bialystok, Poland.
Abstract:
Invasive micropapillary carcinoma (IMPC) is a rare histological type of tumor, first described in invasive ductal breast cancer, than in malignancies in other organs such as lungs, urinary bladder, ovaries or salivary glands. Recent literature data shows that this histological lesion has also been found in cancers of the gastrointestinal system. The micropapillary components are clusters of neoplastic cells that closely adhere to each other and are located in distinct empty spaces. Moreover, clusters of neoplastic cells do not have a fibrous-vascular core. The IMPC cells show reverse polarity resulting in typical ''inside-out'' structures that determines secretary properties, disturbs adhesion and conditions grade of malignancy in gastrointestinal (GI) tract. Invasive micropapillary carcinoma in this location is associated with metastases to local lymph nodes and lymphovascular invasion. IMPC can be a prognostic factor for patients with cancers of the stomach, pancreas and with colorectal cancer since it is related with disease-free and overall survival. The purpose of this review is to present the characterization of invasive micropapillary carcinoma in colon, rectum, stomach and others site of GI tract, and to determine the immunohistological indentification of IMPC in those localization.
Insights
Invasive micropapillary carcinoma (IMPC), a rare tumor type, is increasingly found in the gastrointestinal tract. This review details its characteristics and immunohistological identification in GI cancers.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Invasive micropapillary carcinoma (IMPC) is a rare histological tumor type.
- Initially described in breast cancer, IMPC is now identified in various organs, including the gastrointestinal (GI) tract.
- IMPC is characterized by neoplastic cell clusters in empty spaces, lacking a fibrous-vascular core and exhibiting reverse polarity.
Purpose of the Study:
- To characterize invasive micropapillary carcinoma in the GI tract (colon, rectum, stomach, etc.).
- To determine the immunohistological identification methods for IMPC in these locations.
Main Methods:
- Literature review of invasive micropapillary carcinoma in GI cancers.
- Analysis of histological and immunohistological features of IMPC.
Main Results:
- IMPC in the GI tract is associated with lymph node metastasis and lymphovascular invasion.
- IMPC exhibits "inside-out" structures due to reverse polarity, impacting adhesion and malignancy grade.
- IMPC can serve as a prognostic factor for disease-free and overall survival in GI cancers.
Conclusions:
- Invasive micropapillary carcinoma is a distinct histological entity within GI malignancies.
- Understanding IMPC's characteristics and immunohistological markers is crucial for diagnosis and prognosis.
- Further research into IMPC in the GI tract may improve patient outcomes.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cellular Adaptation IV: Dysplasia and Metaplasia
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Inflammatory Bowel Disease I: Introduction
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

